Avricore Health Inc. (TSXV:AVCR)

Avricore Health Statistics

Total Valuation

Avricore Health has a market cap or net worth of CAD 6.08 million. The enterprise value is 4.80 million.

Market Cap	6.08M
Enterprise Value	4.80M

Important Dates

The last earnings date was Thursday, May 29, 2025.

Earnings Date	May 29, 2025
Ex-Dividend Date	n/a

Share Statistics

Avricore Health has 101.29 million shares outstanding. The number of shares has increased by 1.03% in one year.

Current Share Class	101.29M
Shares Outstanding	101.29M
Shares Change (YoY)	+1.03%
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	10.19%
Owned by Institutions (%)	n/a
Float	90.96M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.48
PB Ratio	3.11
P/TBV Ratio	3.23
P/FCF Ratio	9.40
P/OCF Ratio	7.43
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.76, with an EV/FCF ratio of 7.42.

EV / Earnings	-5.24
EV / Sales	1.17
EV / EBITDA	15.76
EV / EBIT	n/a
EV / FCF	7.42

Financial Position

The company has a current ratio of 7.40

Current Ratio	7.40
Quick Ratio	7.10
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -43.85% and return on invested capital (ROIC) is -2.00%.

Return on Equity (ROE)	-43.85%
Return on Assets (ROA)	-1.69%
Return on Invested Capital (ROIC)	-2.00%
Return on Capital Employed (ROCE)	-3.43%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	26
Asset Turnover	1.66
Inventory Turnover	357.92

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -62.50% in the last 52 weeks. The beta is -1.63, so Avricore Health's price volatility has been lower than the market average.

Beta (5Y)	-1.63
52-Week Price Change	-62.50%
50-Day Moving Average	0.05
200-Day Moving Average	0.10
Relative Strength Index (RSI)	56.10
Average Volume (20 Days)	46,040

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Avricore Health had revenue of CAD 4.10 million and -914,876 in losses. Loss per share was -0.01.

Revenue	4.10M
Gross Profit	1.74M
Operating Income	-66,895
Pretax Income	-914,876
Net Income	-914,876
EBITDA	304,381
EBIT	-66,895
Loss Per Share	-0.01

Balance Sheet

The company has 1.28 million in cash and n/a in debt, giving a net cash position of 1.28 million or 0.01 per share.

Cash & Cash Equivalents	1.28M
Total Debt	n/a
Net Cash	1.28M
Net Cash Per Share	0.01
Equity (Book Value)	1.95M
Book Value Per Share	0.02
Working Capital	1.20M

Cash Flow

In the last 12 months, operating cash flow was 817,998 and capital expenditures -171,292, giving a free cash flow of 646,706.

Operating Cash Flow	817,998
Capital Expenditures	-171,292
Free Cash Flow	646,706
FCF Per Share	0.01

Margins

Gross margin is 42.53%, with operating and profit margins of -1.63% and -22.34%.

Gross Margin	42.53%
Operating Margin	-1.63%
Pretax Margin	-22.34%
Profit Margin	-22.34%
EBITDA Margin	7.43%
EBIT Margin	-1.63%
FCF Margin	15.79%

Dividends & Yields

Avricore Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.03%
Shareholder Yield	n/a
Earnings Yield	-15.05%
FCF Yield	10.64%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 21, 2016. It was a reverse split with a ratio of 0.25.

Last Split Date	Nov 21, 2016
Split Type	Reverse
Split Ratio	0.25

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a